{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:59:42Z","timestamp":1792828782244,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.mjafi.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T06:20:10Z","timestamp":1694499610000},"page":"672-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic significance of extramedullary disease (EMD) detected on pre-transplant 18F-FDG PET\/CT in patients with multiple myeloma: Results of PIPET-M trial"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-6585","authenticated-orcid":false,"given":"Uday","family":"Yanamandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Reddy Gorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhaiyalal","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka Rani","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-8491","authenticated-orcid":false,"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2023.08.007_bib1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.mjafi.2023.08.007_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bjh.13620","article-title":"Time to redefine myeloma","volume":"171","author":"Pratt","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mjafi.2023.08.007_bib3","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1158\/1078-0432.CCR-15-0396","article-title":"PET\/CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma","volume":"21","author":"Zamagni","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mjafi.2023.08.007_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.semnuclmed.2014.08.002","article-title":"Multiple myeloma: 18F-FDG-PET\/CT and diagnostic imaging","volume":"45","author":"Mihailovic","year":"2015","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.mjafi.2023.08.007_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.mjafi.2023.08.007_bib6","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/RLU.0000000000000902","article-title":"Role of FDG-PET\/CT in extramedullary multiple myeloma: correlation of FDG-PET\/CT findings with clinical outcome","volume":"41","author":"Tirumani","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.mjafi.2023.08.007_bib7","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.18632\/oncotarget.2290","article-title":"18 FDG-PET\/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation","volume":"5","author":"Lapa","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.mjafi.2023.08.007_bib8","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.mjafi.2023.08.007_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4143\/crt.2014.010","article-title":"Diagnostic and prognostic implications of spine magnetic resonance imaging at diagnosis in patients with multiple myeloma","volume":"47","author":"Song","year":"2015","journal-title":"Cancer Research and Treatment"},{"key":"10.1016\/j.mjafi.2023.08.007_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/10428194.2012.740562","article-title":"Extramedullary multiple myeloma","volume":"54","author":"Weinstock","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.mjafi.2023.08.007_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411259","article-title":"Genetic abnormalities in extramedullary multiple myeloma","volume":"24","author":"McAvera","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mjafi.2023.08.007_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clml.2014.12.013","article-title":"Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases","volume":"15","author":"Deng","year":"2015","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.mjafi.2023.08.007_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/bjh.13383","article-title":"Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation","volume":"169","author":"Weinstock","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mjafi.2023.08.007_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister","year":"2002","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.mjafi.2023.08.007_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","article-title":"Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results","volume":"33","author":"Nanni","year":"2006","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.mjafi.2023.08.007_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.mjafi.2023.08.007_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","article-title":"Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma","volume":"35","author":"Breyer","year":"2006","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.mjafi.2023.08.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-014-0308-3","article-title":"18F-FDG PET\/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders","volume":"15","author":"Dammacco","year":"2015","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.mjafi.2023.08.007_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jcu.1870080606","article-title":"Reproducibility of echocardiography in chronic congestive heart failure","volume":"8","author":"Unverferth","year":"1980","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.mjafi.2023.08.007_bib20","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.ejrad.2012.06.028","article-title":"Contrast enhanced MRI and 18F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease","volume":"81","author":"Spinnato","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.mjafi.2023.08.007_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"Lutje","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.mjafi.2023.08.007_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/583439","article-title":"Multiple myeloma: a review of imaging features and radiological techniques","volume":"2011","author":"Healy","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.mjafi.2023.08.007_bib23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","article-title":"Value of 18F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma","volume":"38","author":"Haznedar","year":"2011","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.mjafi.2023.08.007_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00259-011-1993-8","article-title":"18F-FDG PET\/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation","volume":"39","author":"Derlin","year":"2012","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.mjafi.2023.08.007_bib25","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.mjafi.2023.08.007_bib26","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/diagnostics13091570","article-title":"Multitracer PET\/CT with [18F] fluorodeoxiglucose and [18F] fluorocholine in the initial staging of multiple myeloma patients applying the IMPeTus criteria: a pilot study","volume":"13","author":"Garrastachu Zumar\u00e1n","year":"2023","journal-title":"Diagnostics"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:39:43Z","timestamp":1745926783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123723001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0377123723001284"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.08.007","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of extramedullary disease (EMD) detected on pre-transplant 18F-FDG PET\/CT in patients with multiple myeloma: Results of PIPET-M trial","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}